Veradermics (MANE) stock
MANE's Quality Score rose 3 points on Fri, Nov 6, to 5. It closed near its high of the day (2 chart checks started).
New listing, trading since Feb 4, 2026. 192 trading days so far, so 1 of the 14 chart checks waits for more history.
Follow MANE's trial news. Pro members can get an alert when Veradermics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Key facts on MANE
| Holding it back | A $70M loss |
| Latest filing | 8-K, Nov 9 |
MANE in the news
ReportExpected to report Thursday, before the open. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 3 reports, -4.2% on average. Past reports ›
Big story
MANE closed +12.4% that day on 1.9x normal volume.
What's next
Mon Nov 9: Investor presentationSlides filed with an 8-K.
1 more date ahead: the IPO anniversary, for Pro members.
MANE catalysts
After its last 3 reports it closed -4.2% on average, higher 0 of 3 times.
What's next for MANE, and how long its cash lasts
Next step the company has named
Cash runway
$820M in cash
Dilution on the horizon
No shelf registration or at-the-market program on file in the last three years.
Insiders
Director MONTANOVA CAPITAL, LLC sold 750,000 shares on Aug 19. 7 more insider trades this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Why MANE scores 5
Below Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means
- +5Chart checks 5 of 14 firing right now, one point each
- +1Long-term trend 192 sessions listed, no 200-day average yet, near its 52-week high
- Run-up adds
- Profit subtracts
- Volatility subtracts
How MANE ranks in Pharma
MANE is #29 of 90 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 29 |
Cash and short-term investments: MANE $820M, VRDN $982M, AXSM $320M, EWTX $72.3M.
When does MANE report earnings, and what happens after?
Expected to report Thu Nov 12, before the open (in 3 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
What MANE reported on Aug 11, 2026
The quarter
The figures are not read from the release yet.
“The increase in R&D expenses of $4.3 million was primarily due to increases in clinical development and other development expenses of VDPHL01 and an increase in payroll and personnel-related costs, including stock-based compensation and increased headcount, as compared to the same period in the prior year.”
Where the sales came from
MANE's results filing gives no sales by line in a table we read.
The outlook
No outlook figures read from this release.
In the company's words
“With enrollment in Study ‘306’ now complete, we look forward to a catalyst-rich remainder of 2026 as we progress toward topline data from the confirmatory Phase 3 Study ‘304’ in men and 12-month data from Study ‘302’, both anticipated in the second half of 2026.”
From its results filing (SEC filing · Aug 11)
The numbers
- $5.4B
- today
Close after the report, last 3
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Aug 11, 2026 | -1.0% | -1.6% | -2.3% |
| May 12, 2026 | +0.8% | -3.9% | -7.2% |
| Mar 30, 2026 | -1.0% | -7.1% | -2.6% |
MANE has 5 of 14 chart checks firing
MANE RSI on Nov 6: 57.9, above its 50-day average
RSI 57.9, MACD below signal. Not scored.
The deep dive on MANE
- What it does and how it makes money
- Where it standsSEC filing · Apr 30, 2026
- Who holds and trades it
- Against its closest peers
MANE insider trades
2 insiders sold $91.1M across 5 filings in the last 6 months. No open-market buys on record. The newest:
MANE's officers and directors
Officers and directors with a Form 4 in the last 12 months.
Which ETFs hold MANE?
In ETFs: MANE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
About Veradermics
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Listed on NYSE on Feb 4, 2026, and is 716% above its $17 offer price now. The offer price is from Massive's IPO calendar.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Pro members see every line of every stock's score.
- What would turn MANE's score around: 5 things
- 7 more filings explained, a plain line each
- Real-time prices, no delay
Straight AnswersStraight Answers
What does MANE's Quality Score say?
MANE scores 5 today, which Breakaway calls Below Average. It is #29 of 90 in Pharma by Quality Score, with 5 of 14 chart checks firing. Shares: 54.3 times the count a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is MANE's Quality Score?
MANE scores 5 today, which Breakaway calls Below Average (0 to 5). That is #29 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MANE's 5.
Are insiders buying MANE?
2 insiders sold $91.1M across 5 filings in the last 6 months. No open-market buys on record. The newest is Montanova Capital, LLC, Director, who sold $74.1M on Aug 19. Every filing, with the scored weight, for Pro members.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.